. 2017 Dec 5;24(12):e00237-17. doi: 10.1128/CVI.00237-17

TABLE 2.

Summary of HDX analysis of RiVax bound by cluster I to IV MAbs

MAb	Cluster	Strongly protected elements of RiVax^a
MAb	Cluster	Peptide no.	Residue no.	Secondary structure(s)
PB10	I	34–36, 38–41	94–107	α-Helix B
		114	243–244

R70		34–41	94–107	α-Helix B

WECB2		32–36	94–107	α-Helix B
		38	95–107	α-Helix B
		43–44	110–122	β-Strand h

SyH7	II	2–4	14–24	α-Helix A
		80–86	184–207	α-Helix F, α-helix G

PA1		80–85	184–204	α-Helix F, α-helix G

TB12		16–18	60–69	β-Strand d
		66	155–164	α-Helices D-E

PH12		17–19	62–69	β-Strand d
		65–66	154–164	α-Helices D-E

IB2	III	46–50	121–135	α-Helix C
		52	129–135	α-Helix C
		88, 89, 91	207–217	α-Helix G
		123–124	251–254

GD12	IV	8, 9, 11–13	35–59	β-Strands b, c, and d
JD4		123–125	251–255

Peptides and corresponding residues on RiVax are indicated in Table S1.